IGF-1 LR3
Research useModified growth factor (IGF-1 analogue)
Last updated 29 October 2026
IGF-1 LR3 is a laboratory modified version of insulin like growth factor 1, a natural growth signal that works downstream of growth hormone. The changes make it last far longer in the body. It is marketed for muscle growth, has no UK marketing authorisation, and carries real safety concerns.
Key points
- IGF-1 LR3 is a modified form of IGF-1, a growth factor the body makes in response to growth hormone.
- The modifications make it last around a day in the body, far longer than natural IGF-1, which lasts only minutes.
- It is marketed for muscle growth and recovery, with little direct human evidence.
- It is not a licensed medicine in the UK, and growth factors are prohibited in sport.
Quick facts
- What it is
- Modified, long acting IGF-1 (growth factor)
- Marketed for
- Muscle growth and recovery
- UK status
- Not a licensed medicine; sold for research use
- Human evidence
- Very limited; marketing ahead of data
- In sport
- On the WADA Prohibited List
How it works
IGF-1 is the signal through which much of growth hormone's effect is carried out, telling cells to grow and divide and helping muscle take up nutrients. IGF-1 LR3 is engineered to resist the proteins that normally rein IGF-1 in, so it stays active far longer. That longer action is exactly what makes it attractive for muscle building and what makes its effects harder to control.
What the evidence shows
There is very little direct human evidence for IGF-1 LR3 as used in sport and bodybuilding. The science of IGF-1 itself is well understood, but that does not establish that injecting a long acting version is safe or effective for building muscle. The marketing claims run well ahead of any controlled human data.
What it does not settle
- There are no proper human trials of IGF-1 LR3 for muscle or performance.
- Long term safety is unknown, and products are not quality assessed.
- The right dose, if any, has never been established in trials.
Side effects
Common
- Because it acts on blood sugar much as insulin does, it can cause low blood sugar, with shakiness, sweating and confusion.
- Injection site reactions and fluid retention are also reported.
Less common but serious
- Severe low blood sugar can be dangerous. IGF-1 also drives cell growth, so there is a real theoretical concern about encouraging the growth of cancers.
- Because there is no licensed product, the dose, purity and contents of material bought online cannot be verified.
Report any suspected side effect through the MHRA Yellow Card scheme.
UK legal status and access
IGF-1 LR3 has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is sold online labelled for research use. Injecting a potent growth factor of unknown quality carries serious risks.
Common questions
What is IGF-1 LR3?
A laboratory modified, long acting version of the natural growth factor IGF-1, marketed for muscle growth.
Is it safe?
It can cause dangerous drops in blood sugar, and as a growth factor it raises a theoretical cancer concern. Human safety data is lacking.
Is it allowed in sport?
No. IGF-1 and other growth factors are on the WADA Prohibited List.
The licensed route
There is no licensed IGF-1 LR3. For training, recovery or body composition, a registered clinician, physiotherapist or qualified coach can advise on safe, evidence based approaches.
Factual reference only, not medical advice. We give no dosing for unlicensed compounds.